🔎 Trials Near Me

Home › Multiple Sclerosis › Alabama

Pag-aaral pangklinika para sa Multiple Sclerosis sa Alabama

8 pag-aaral para sa Multiple Sclerosis ang naghahanap ng mga kalahok sa mga site sa Alabama.

Mga Lungsod sa Alabama

Opisyal na teksto ng pag-aaral (English)

Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis

  • University of Alabama at Birmingham, Birmingham
Nagre-recruit
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07475377

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Birmingham
  • TG Therapeutics Investigational Trial Site, Cullman
  • TG Therapeutics Investigational Trial Site, Huntsville
  • at 1 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06433752

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • North Central Neurology Associates- Site Number : 8401100, Cullman
  • Alabama Neurology Associates- Site Number : 8400115, Homewood
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07325292

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • UAB, Psychiatry and Behavioral Neurology, Birmingham
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07002034

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  • Alabama Neurology Associates, Birmingham
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06782490

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Alabama Neurology Associates PC, Birmingham
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07225504

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

  • University of Alabama at Birmingham Medical Center, Birmingham
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT03759522

Care in Multiple Sclerosis (MS)

  • University of Alabama at Birmingham, Birmingham
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT07011914

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.